cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ideaya Biosciences Inc
2 own
3 watching
Current Price
$17.03
$0.47
(2.84%)
logo-idya
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
818.98M
52-Week High
52-Week High
19.14
52-Week Low
52-Week Low
8.14
Average Volume
Average Volume
0.91M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization818.98M
icon52-Week High19.14
icon52-Week Low8.14
iconAverage Volume0.91M
iconDividend Yield--
iconP/E Ratio--
What does the Ideaya Biosciences Inc do?
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company s lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase I/II study in metastatic uveal melanoma, skin melanoma, and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Read More
How much money does Ideaya Biosciences Inc make?
News & Events about Ideaya Biosciences Inc.
Ticker Report
4days ago
IDEAYA Biosciences, Inc. (NASDAQ:IDYA Get Rating) Stock analysts at Capital One Financial issued their FY2027 EPS estimates for shares of IDEAYA Biosciences in a report issued on Tuesday, January 24th. Capital One Financial analyst Z. Jallah forecasts that the company will earn $1.90...
PR Newswire
4 months ago
IDEAYA Announces Pricing of Public Offering of Common Stock IDEAYA Announces Pricing of Public Offering of Common Stock PR Newswire SOUTH SAN FRANCISCO, Calif., Sept. 14, 2022 SOUTH SAN FRANCISCO, Calif., Sept. 14, 2022 /PRNewswire/ -- IDEAYA Biosciences, Inc.(Nasdaq: IDYA) today announced the...
PR Newswire
5 months ago
IDEAYA Biosciences to Participate in Investor Conferences in September 2022 IDEAYA Biosciences to Participate in Investor Conferences in September 2022 PR Newswire SOUTH SAN FRANCISCO, Calif., Aug. 30, 2022 SOUTH SAN FRANCISCO, Calif., Aug. 30, 2022 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ...
Ticker Report
10 months ago
Wedbush restated their outperform rating on shares of IDEAYA Biosciences (NASDAQ:IDYA Get Rating) in a report published on Wednesday morning, MarketBeat.com reports. The brokerage currently has a $34.00 price target on the stock. Wedbush also issued estimates for IDEAYA Biosciences Q1...
Frequently Asked Questions
Frequently Asked Questions
What is Ideaya Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Ideaya Biosciences Inc shares?
plus_minus_icon
How can I buy Ideaya Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Ideaya Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ideaya Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Ideaya Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Ideaya Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ideaya Biosciences Inc?
plus_minus_icon
What percentage is Ideaya Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ideaya Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$17.03
$0.47
(2.84%)
logo-idya
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00